Home
ACTL Immunotherapy
Functional Mechanism
Advantages
Safety
Indications
Protocols
Steps
Patents
Translational Medicine
Treatment & Prevent
Conditions
Case Studies
Cooperative Hospital
Early Detection
Prevention
Nursing & Care
News
Partnership
About Us
Company Introduction
Our Culture
Milestones
Qualification & Honor
Team of Experts
Activities
Jobs
Contact Us
简体
繁体
英文
Industrial News
Coperate News
Industrial News
Policies & Regulations
03-22 2017
Cancer Treatment "National Team" Chinese Academy of Medical Sciences Cancer Hospital settled in Shenzhen
In the past, the treatment of cancer patients in Shenzhen has always chosen to go to Beijing, Sh...
Details
03-21 2017
2017 China Urban Cancer Latest Data Report
Cancer statistics show that in China, there are 4.29 million new cancer cases each year, accountin...
Details
03-13 2017
Member Ling Feng: The Wei Zexi incident should not be the end sign of cellular immunotherapy
"After the Wei Zexi incident, the domestic cellular immunotherapy research process has almost sta...
Details
03-10 2017
Detailed explanation of the evaluation criteria for the efficacy of anti-tumor cell immunotherapy irRC
In 2009, internationally recommended and formulated a new standard for the efficacy of tumor immuno...
Details
03-07 2017
[Follow the two sessions] CPPCC member Luo Yongzhang suggested: Include cancer prevention physical examination in medical insurance
The incidence of cancer in my country is close to the world level, but the mortality rate is higher...
Details
First
<<
6
7
8
9
10
>>
11
